首页> 外文期刊>Morbidity and mortality weekly report >Update: hydrogen cyanamide-related illnesses--Italy, 2002-2004.
【24h】

Update: hydrogen cyanamide-related illnesses--Italy, 2002-2004.

机译:更新:与氰氨氢有关的疾病-意大利,2002-2004年。

获取原文
获取原文并翻译 | 示例
           

摘要

Hydrogen cyanamide is used in agriculture as a plant growth regulator and is applied to many deciduous plants to stimulate uniform budbreak after dormancy, resulting in uniform flowering and maturity. Hydrogen cyanamide is highly toxic, and adverse health effects from contact include severe irritation and ulceration of the eyes, skin, and respiratory tract. The substance also inhibits aldehyde dehydrogenase and can produce acetaldehyde syndrome (e.g., vomiting, parasympathetic hyperactivity, dyspnea, hypotension, and confusion) when exposure coincides with alcohol use. After Dormex (Degussa AG, Trostberg, Germany), a pesticide product containing hydrogen cyanamide (49% by weight), was introduced in Italy in 2000, a total of 23 cases of acute illness associated with exposure to this chemical were identified in early 2001. This led to a temporary suspension of sales and usage of Dormex on February 23, 2002, and strengthening of protective measures, as specified on the pesticide label when sales were resumed on June 20, 2003. This report describes 28 additional cases of hydrogen cyanamide-related illness that occurred during 2002-2004, 14 of which occurred after sales resumed. These illnesses suggest that the preventive measures adopted in Italy in 2003 to protect workers using hydrogen cyanamide are inadequate. Workers exposed to hydrogen cyanamide should be provided adequate information, training, personal protective equipment (PPE), and engineering controls.
机译:氰氨化氢在农业中用作植物生长调节剂,并应用于许多落叶植物,以在休眠后刺激均匀的芽裂,从而导致均匀的开花和成熟。氰氨化氢具有剧毒,接触所产生的不利健康影响包括对眼睛,皮肤和呼吸道的严重刺激和溃疡。当暴露与饮酒同时发生时,该物质还抑制醛脱氢酶并会产生乙醛综合症(例如,呕吐,副交感神经过度活跃,呼吸困难,低血压和意识模糊)。自2000年在意大利引入Dormex(德国Trostberg的Degussa AG)后,该农药产品含有氰氨化氢(按重量计占49%),在2001年初共发现了23种与该化学品接触引起的急性疾病病例。 。这导致Dormex于2002年2月23日暂时停止销售和使用,并按照2003年6月20日恢复销售时农药标签上的规定加强了保护措施。本报告还介绍了28例氰氨化氢相关疾病,发生于2002年至2004年,其中14起发生在恢复销售后。这些疾病表明,意大利于2003年采取的预防措施不足以保护使用氰氨氢的工人。应当为接触氨氰氢的工人提供足够的信息,培训,个人防护设备(PPE)和工程控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号